Abstract. Canonical Wnt signaling is critical for the control of osteoblast differentiation in human mesenchymal stem cells. MicroRNAs (miRs) are essential regulators of cell differentiation by post-transcriptional regulation of target gene expression. The aim of the present study was to investigate the molecular mechanism by which miR-142-3p promotes osteoblastic differentiation using the human fetal osteoblastic 1.19 (hFOB1.19), real-time PCR and western blot analysis. Results showed an increased expression of miR-142-3p during osteoblast differentiation in the mesenchymal precursor cell line, hFOB1.19. In addition, the ectopic over expression of miR-142-3p promoted hFOB1.19 differentiation, whereas the inhibition of miR-142-3p repressed differentiation. The expression of miR-142-3p was positively correlated with β-catenin, an important protein in Wnt signaling. The adenomatous polyposis coli (APC) gene was a direct target of miR-142-3p, whereby miR-142-3p promoted Wnt signaling through inhibition of APC, leading to accumulation and nuclear translocation of β-catenin. Therefore, miR-142-3p may be an essential mediator of osteoblast differentiation and a new therapeutic strategy for osteogenesis disorders.
Introduction
Mesenchymal stem cells (MSCs) differentiate along several lineages, including osteoblasts, adipocytes and myoblasts, in response to various environmental stimuli (1) . MSC differentiation is tightly regulated at transcriptional and post-transcriptional levels (2) . A number of genes are important for the regulation of MSC differentiation, including bone morphogenetic protein and runt-related tran scription factor 2 (Runx2) (3, 4) . Canonical Wnt signaling is also critical for the control of bone formation (5) as it accelerates the differentiation of osteochondral progenitors towards the osteoblastic lineage, while promoting early MSC proliferation (6) . In addition, Wnt signaling functions as an adipogenic switch, whereby loss of Wnt/β-catenin signaling drives the shift of preosteoblasts from osteoblast to adipocyte differentiation (5) .
The canonical Wnt pathway requires binding of Wnt to low-density lipoprotein receptor-related proteins 5 and 6, Frizzled receptor and Dishevelled. In the absence of Wnt stimulation, cytoplasmic β-catenin is recruited by a multiprotein destruction complex consisting of two scaffold proteins, adenomatous polyposis coli (APC) and axin and two kinases, glycogen synthase kinase 3β (GSK3β) and casein kinase 1a (CKI). This complex leads to constitutive phosphorylation of β-catenin and its subsequent proteasomal degradation. Wnt receptor binding and activation inhibits GSK3β activity, leading to accumulation and nuclear translocation of β-catenin, which functions as a transcriptional coactivator and drives the transcription of genes essential for osteoblast differentiation. Numerous factors regulate osteoblast differentiation through the Wnt-mediated pathway (7) .
MicroRNAs (miRNAs/miRs) negatively regulate translation or induce degradation of target mRNAs by binding to their 3' untranslated regions (UTRs). miRNAs are potent regulators of diverse physio logical processes, including cell proliferation, differentiation and apoptosis (8) . It was recently reported that miRNAs are essential for the regulation of osteoblastic differentiation (2) . Huang et al demonstrated that miR-204 inhibits osteoblast differentiation by targeting Runx2 in bone marrow-derived MSC (4). miR-138 represses osteoblast differentiation by inhibiting FAK (9) . By contrast, miR-29b promotes osteoblast differentiation by targeting inhibitors of this process (10) . A number of miRNAs regulate osteoblast differentiation through the Wnt signaling pathway. miR-29a potentiates Wnt signaling and regulates osteoblast differentiation (6) . miR-27 positively regulates osteoblast differentiation by targeting APC (11) . miR-142-3p regulates myeloid and erythroid differentiation (12, 13) , however, the role of miR-142-3p in regulating osteoblast differentiation remains unknown.
In the present study, the molecular mechanism by which miR-142-3p promotes osteoblastic differentiation miR-142-3p promotes osteoblast differentiation by modulating Wnt signaling was investigated. Results showed that miR-142-3p activated Wnt signaling and promoted osteoblast differentiation by repressing APC expression.
Materials and methods
Cell culture. Real-time quantitative PCR. Total RNA was extracted with TRIzol (Invitrogen Life Technologies). cDNA was synthesized using 1 µg RNA with a reverse transcription kit (Tiangen Biotech, Beijing, China). miRNAs and the synthesized cDNAs were prepared with a microRNA extraction kit (Tiangen Biotech). Real-time PCR was performed with a standard SYBR-Green PCR kit from Toyobo (Osaka, Japan). Primers used included: β-actin F: 5'-AGCCATGTACGTTGCTA-3', R: 5'-AGTCCGCCTAGAAGCA-3'; Runx2 F: 5'-TCTTCACA AATCCTCCCC-3', R: 5'-TGGATTAAAAGGACTTGG-3'; osteocalcin (OC) F: 5'-CATGAGAGCCCTCACA-3' , R: 5'-AGA GCGACACCCTAGAC-3'; and alkaline phosphatase (ALP) F: 5'-ACGTGGCTAAGAATGTCATC-3' , R: 5'-CTGGTAGGC GATGTCCTTA-3'. Primers for miR-142-3p and U6 snRNA were obtained from GeneCopoeia. Runx2, OC and ALP mRNA levels were normalized to β-actin and the expression of miR-142-3p was normalized to U6 snRNA.
Measurement of cell differentiation.
Osteoblast marker transcripts (Runx2, OC and ALP) were detected by real-time PCR as described. ALP activity was measured as previously described (14) .
Western blot analysis.
Western blot analysis to measure APC and β-catenin protein levels was performed as previously described (15) . Anti-APC and anti-β-catenin primary antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Blots were incubated with anti-mouse or anti-rabbit IgG conjugated to IRDye™ (800CW) for 1 h at 37˚C and visualized using the Odyssey Infrared Imaging System (Licor Biosciences, Lincoln, NE, USA).
Statistical analysis. Data were expressed as the mean ± SE. Data were analyzed using the Student's t-test. P<0.05 was considered to indicate a statistically significant difference.
Results

Upregulated miR-142-3p promotes osteoblastic differ entiation.
Previous studies have demonstrated that miR-142-3p regulates myeloid and erythroid differentiation. We detected miR-142-3p expression during hFOB1.19 cell differentiation. miR-142-3p increased in hFOB1.19 cells maintained in osteoblastic differentiation medium (Fig. 1) .
To investigate the potential function of miR-142-3p in hFOB1.19 differentiation, cells were transfected with control vector, pre-miR-142 or anti-miR-124. Pre-miR-142 enhanced osteoblastic differentiation, which was indicated by higher expression of the osteoblast marker genes Runx2, OC and ALP (16) , accompanied by increased ALP activity in comparison to cells transfected with control vector. By contrast, ALP activity and osteoblast-specific genes were identified to be significantly decreased when hFOB1.19 cells were transfected with anti-miR-142, a blocker of miR-142 (Fig. 2) . These data indicate that upregulation of miR-142-3p positively regulated hFOB1.19 differentiation, whereas inhibition of miR-142-3p negatively regulated hFOB1.19 differentiation.
miR-142-3p targets APC via predicted binding sites. Prediction
Algorithms miRbase and Targetscan were used to select potential targets of miR-142-3p in osteoblastic differentiation. miR-142-3p targets APC, which acts as a regulatory factor in Wnt signaling (Fig. 3A) . In addition, luciferase reporter constructs containing possible binding sites and specific mutations within the 3' UTR of APC mRNA were generated. Wild-type and mutated APC 3' UTR luciferase reporter constructs were cotransfected into HEK293 cells with the miR-142-3p overexpression plasmid or a control vector. Significant inhibition was observed when miR-142-3p was cotransfected with the wild-type APC 3' UTR in HEK293 cells, whereas mutated APC 3' UTR luciferase activity was altered marginally in comparison to the vector control (Fig. 3B) . The reporter assay demonstrated that miR-142-3p significantly repressed luciferase expression and mutation of four nucleotides in the binding sites led to complete abrogation of this suppressive effect. Moreover, the ectopic expression of miR-142-3p significantly reduced APC protein levels (Fig. 3C) 
Discussion
miRNAs are small non-coding RNA molecules that post-transcriptionally regulate gene expression by targeting sequences within the 3' UTR of target mRNAs. miRNAs are involved in several essential biological processes, including tumorigenesis, hormone signaling and differentiation (8) and are critical for the control of adipogenesis, myeloblast differentiation and osteoblastogenesis (2) . In the present study, miR-142-3p was identified to positively regulate osteoblastic differentiation by promoting Wnt signaling. miR-142-3p is specifically associated with the regulation of hematopoietic lineage specification, obesity and periodontitis by targeting diverse molecules, including glucocorticoid receptor-α and IL-6 (18, 19) . Kim et al reported that miR-142-3p is involved in TGF-β3-mediated region-dependent chondrogenesis through regulation of ADAM9 (20) . miR-142-3p is an essential regulator of myeloid differentiation and downregulation of miR-142-3p is involved in the development of acute myeloid leukemia (12, 18) . miR-142-3p is also involved in erythroid differentiation of human embryonic stem cells (13) . However, the potential function of miR-142-3p in the regulation of osteoblastic differentiation remains unclear. Our results showed that miR-142-3p levels increased in differentiating hFOB1.19 cells and over expression promoted differentiation. When miR-142-3p function was inhibited, Runx2, OC and ALP mRNA levels were significantly reduced, accompanied by decreased ALP activity. In addition, miR-142-3p was observed to target APC, an important Wnt signaling molecule. The luciferase reporter assay revealed that miR-142-3p significantly inhibited APC 3' UTR expression. Western blot analysis also confirmed that miR-142-3p significantly suppressed APC protein levels in differentiating hFOB1.19 cells.
APC is a scaffold protein for GSK3β/CKI-mediated phosphorylation and subsequent degradation of β-catenin, the Wnt signaling effector. Without Wnt stimulation, β-catenin interacts with a multiprotein complex of APC, axin, GSK3β and CKI, known as the destruction complex, leading to phosphorylation of β-catenin by GSK3β and CKI. Once phosphorylated, β-catenin is ubiquitinated and degraded by the proteasome. Activation of Wnt signaling may inhibit GSK3β activity and result in the accumulation of non-phosphorylated β-catenin in the cytoplasm and nuclear translocation. Binding of the Tcf/Lef family of transcription factors promotes target gene expression (17) . Blocking β-catenin binding sites on APC inhibits β-catenin degradation and leads to unchecked Wnt signaling (21) . Therefore, APC inhibition by miR-142-3p may disrupt the destruction complex, induce nuclear accumulation of β-catenin and activate Wnt signaling.
The present study has demonstrated that miR-142-3p positively regulates osteoblast differentiation by targeting APC, indicating that miR-142-3p may be an important candidate therapeutic agent for treatment of osteogenesis disorders.
